...
首页> 外文期刊>Systematic Reviews >Effects of perioperative statin use on cardiovascular complications in patients submitted to non-cardiac surgery: protocol for a systematic review, meta-analysis, and trial sequential analysis
【24h】

Effects of perioperative statin use on cardiovascular complications in patients submitted to non-cardiac surgery: protocol for a systematic review, meta-analysis, and trial sequential analysis

机译:非心脏手术患者围手术期他汀类药物使用对心血管并发症的影响:系统评价,荟萃分析和试验顺序分析的方案

获取原文
           

摘要

Background Preliminary evidence suggests statins may reduce major perioperative vascular events. However, evidence is limited to observational studies, underpowered trials, and non-comprehensive systematic reviews. This review aims to assess the effects of perioperative statin use on cardiovascular complications in patients submitted to non-cardiac surgery. Methods We will search MEDLINE/PubMed, EMBASE, LILACS, CENTRAL, Web of Science, and CINAHL for randomized controlled trials assessing the effects of perioperative statin use in adults undergoing non-cardiac surgery and reporting cardiovascular complications. For patients already using statins for hyperlipidemia, a preoperative loading dose of statin is required in the experimental group. We will place no language or publication restriction on our search. Teams of two reviewers will independently assess eligibility and risk of bias, and will extract data from the included trials. Our primary outcome is a combination of cardiovascular mortality or non-fatal myocardial infarction. We will also assess the following outcomes: individual components of the primary outcome, all-cause mortality, total myocardial infarction, elevated troponin in the first seven postoperative days, total stroke, total venous thromboembolism, postoperative atrial fibrillation, elevation of creatine phosphokinase or liver enzymes, and rates of myalgia or rhabdomyolysis. We will conduct meta-analyses using random-effects model and will use trial sequential analysis to establish monitoring boundaries to limit global type I error due to repetitive testing for our primary outcome. We will rate the quality of evidence using the GRADE system. Discussion The results of this systematic review may help to inform clinical practice and also the design of future large-scale randomized trials. Systematic review registration PROSPERO CRD42016035987
机译:背景初步证据表明他汀类药物可减少围手术期的主要血管事件。但是,证据仅限于观察性研究,功能不足的试验和非综合性系统评价。这篇综述旨在评估围手术期使用他汀类药物对非心脏手术患者心血管并发症的影响。方法我们将在MEDLINE / PubMed,EMBASE,LILACS,CENTRAL,Web of Science和CINAHL上进行随机对照试验,以评估围手术期他汀类药物在接受非心脏手术并报告心血管并发症的成年人中的作用。对于已经使用他汀类药物治疗高脂血症的患者,在实验组中需要术前负荷他汀类药物的剂量。我们将对搜索没有语言或出版物的限制。由两名审稿人组成的小组将独立评估资格和存在偏见的风险,并将从纳入的试验中提取数据。我们的主要结局是心血管疾病死亡率或非致命性心肌梗死的综合结果。我们还将评估以下结局:主要结局的各个组成部分,全因死亡率,总心肌梗塞,术后前7天的肌钙蛋白升高,总卒中,总静脉血栓栓塞,术后心房颤动,肌酸磷酸激酶或肝脏升高酶和肌痛或横纹肌溶解的发生率。我们将使用随机效应模型进行荟萃分析,并将使用试验序贯分析来建立监控边界,以限制由于对主要结果进行重复测试而导致的总体I型错误。我们将使用GRADE系统评估证据的质量。讨论该系统评价的结果可能有助于为临床实践提供参考,也有助于将来进行大规模的随机试验设计。系统审查注册PROSPERO CRD42016035987

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号